{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:44:45Z","timestamp":1793108685826,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,14]],"date-time":"2027-07-14T00:00:00Z","timestamp":1815523200000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM149235"],"award-info":[{"award-number":["R35GM149235"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","award":["AZ-DBG-23-1151311-01-IBCD"],"award-info":[{"award-number":["AZ-DBG-23-1151311-01-IBCD"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01-BX005336"],"award-info":[{"award-number":["I01-BX005336"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["F30CA281056"],"award-info":[{"award-number":["F30CA281056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007345","name":"University of Arizona Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007899","name":"University of Arizona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007899","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.immuni.2026.05.005","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:47:19Z","timestamp":1781189239000},"page":"1999-2014.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunoediting restricts clonal neoantigens in primary, treatment-naive human tumors"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2665-0218","authenticated-orcid":false,"given":"Elizabeth S.","family":"Borden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Kantzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alysia","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Leibovit-Reiben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Stockard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirudh","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Mangold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan N.","family":"Gutenkunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie J.","family":"LaFleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth H.","family":"Buetow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-8033","authenticated-orcid":false,"given":"Karen Taraszka","family":"Hastings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2026.05.005_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2026.05.005_bib2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.192.5.755","article-title":"Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma","volume":"192","author":"Smyth","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.005_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V97.1.192","article-title":"Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis","volume":"97","author":"Street","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2026.05.005_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.20020063","article-title":"Suppression of lymphoma and epithelial malignancies effected by interferon gamma","volume":"196","author":"Street","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.005_bib5","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1084\/jem.184.5.1781","article-title":"Decreased tumor surveillance in perforin-deficient mice","volume":"184","author":"van den Broek","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.005_bib6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.005_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02799","article-title":"Neoantigen Fitness Model Predicts Lower Immune Recognition of Cutaneous Squamous Cell Carcinomas Than Actinic Keratoses","volume":"10","author":"Borden","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2026.05.005_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41586-022-04735-9","article-title":"Neoantigen quality predicts immunoediting in survivors of pancreatic cancer","volume":"606","author":"\u0141uksza","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.005_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/2159-8290.CD-16-0828","article-title":"Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer","volume":"7","author":"Anagnostou","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2026.05.005_bib10","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/s41591-024-03240-y","article-title":"Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab","volume":"30","author":"Alban","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.05.005_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-019-1032-7","article-title":"Neoantigen-directed immune escape in lung cancer evolution","volume":"567","author":"Rosenthal","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.005_bib12","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/0008-5472.CAN-21-3717","article-title":"Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution","volume":"82","author":"Wu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2026.05.005_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41588-023-01313-1","article-title":"Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors","volume":"55","author":"Zapata","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2026.05.005_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.05.005_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-018-1434-0","article-title":"Negative selection in tumor genome evolution acts on essential cellular functions and the immunopeptidome","volume":"19","author":"Zapata","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2026.05.005_bib16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature10755","article-title":"Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting","volume":"482","author":"Matsushita","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.005_bib17","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41588-023-01499-4","article-title":"Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity","volume":"55","author":"Westcott","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2026.05.005_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature10803","article-title":"Expression of tumour-specific antigens underlies cancer immunoediting","volume":"482","author":"DuPage","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.005_bib19","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/s41588-019-0532-6","article-title":"Lack of detectable neoantigen depletion signals in the untreated cancer genome","volume":"51","author":"Van den Eynden","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2026.05.005_bib20","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1158\/0008-5472.CAN-22-2497","article-title":"Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution-Letter","volume":"83","author":"Claeys","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2026.05.005_bib21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/DSS.0000000000001038","article-title":"Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients","volume":"43","author":"Gonzalez","year":"2017","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.immuni.2026.05.005_bib22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00007890-199003000-00006","article-title":"Incidence of skin cancer after renal transplantation in The Netherlands","volume":"49","author":"Hartevelt","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.immuni.2026.05.005_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/S0190-9622(00)90154-3","article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens","volume":"42","author":"Jensen","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.immuni.2026.05.005_bib24","first-page":"513","article-title":"Incidence of skin cancer in 5356 patients following organ transplantation","volume":"143","author":"Lindel\u00f6f","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.immuni.2026.05.005_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hed.23283","article-title":"Cancer of the head and neck region in solid organ transplant recipients","volume":"36","author":"Rabinovics","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.immuni.2026.05.005_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2026.05.005_bib27","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2026.05.005_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/bs.mie.2019.05.056","article-title":"Deconvoluting tumor-infiltrating immune cells from RNA-seq data using quanTIseq","volume":"636","author":"Plattner","year":"2020","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.immuni.2026.05.005_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41525-021-00226-4","article-title":"The landscape of driver mutations in cutaneous squamous cell carcinoma","volume":"6","author":"Chang","year":"2021","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/j.immuni.2026.05.005_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06027-1","article-title":"The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.05.005_bib31","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jid.2023.01.006","article-title":"Mutational Landscape of Normal Human Skin: Clues to Understanding Early-Stage Carcinogenesis in Keratinocyte Neoplasia","volume":"143","author":"Kim","year":"2023","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.immuni.2026.05.005_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013148","article-title":"Structural changes from wild-type define tumor-rejecting neoantigens","volume":"13","author":"Adams","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.immuni.2026.05.005_bib33","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"47","author":"Alexandrov","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2026.05.005_bib34","article-title":"The mutational signatures of formalin fixation on the human genome","volume":"13","author":"Guo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.05.005_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaz3199","article-title":"Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes","volume":"5","author":"Lu","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2026.05.005_bib36","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.05.005_bib37","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41588-018-0200-2","article-title":"Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors","volume":"50","author":"Miao","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2026.05.005_bib38","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/genetics\/162.4.2025","article-title":"Approximate Bayesian computation in population genetics","volume":"162","author":"Beaumont","year":"2002","journal-title":"Genetics"},{"key":"10.1016\/j.immuni.2026.05.005_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2021.06.008","article-title":"Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy","volume":"517","author":"Wang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.immuni.2026.05.005_bib40","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4049\/jimmunol.2100700","article-title":"NeoScore Integrates Characteristics of the Neoantigen:MHC Class I Interaction and Expression to Accurately Prioritize Immunogenic Neoantigens","volume":"208","author":"Borden","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2026.05.005_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature24473","article-title":"A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy","volume":"551","author":"\u0141uksza","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.005_bib42","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.05.005_bib43","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cell.2020.09.015","article-title":"Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction","volume":"183","author":"Wells","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.05.005_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-019-0679-x","article-title":"pTuneos: prioritizing tumor neoantigens from next-generation sequencing data","volume":"11","author":"Zhou","year":"2019","journal-title":"Genome Med."},{"key":"10.1016\/j.immuni.2026.05.005_bib45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41588-022-01273-y","article-title":"MHC II immunogenicity shapes the neoepitope landscape in human tumors","volume":"55","author":"Kim","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2026.05.005_bib46","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s43018-021-00247-z","article-title":"Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer","volume":"2","author":"Westcott","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.immuni.2026.05.005_bib47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00251-010-0441-4","article-title":"NetCTLpan: pan-specific MHC class I pathway epitope predictions","volume":"62","author":"Stranzl","year":"2010","journal-title":"Immunogenetics"},{"key":"10.1016\/j.immuni.2026.05.005_bib48","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2026.05.005_bib49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/imm.12160","article-title":"NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery","volume":"141","author":"J\u00f8rgensen","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.immuni.2026.05.005_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142823","article-title":"An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection","volume":"131","author":"Brennick","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.immuni.2026.05.005_bib51","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1084\/jem.20141308","article-title":"Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity","volume":"211","author":"Duan","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.005_bib52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/1467-9868.00293","article-title":"Estimating the number of clusters in a data set via the gap statistic","volume":"63","author":"Tibshirani","year":"2001","journal-title":"J. R. Stat. Soc."},{"key":"10.1016\/j.immuni.2026.05.005_bib53","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s43018-021-00197-6","article-title":"A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types","volume":"2","author":"Gartner","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.immuni.2026.05.005_bib54","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.immuni.2023.09.002","article-title":"Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction","volume":"56","author":"M\u00fcller","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.005_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-024-06460-7","article-title":"Frequency-dependent selection of neoantigens fosters tumor immune escape and predicts immunotherapy response","volume":"7","author":"Chen","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.immuni.2026.05.005_bib56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-024-01091-9","article-title":"Vax-Innate: improving therapeutic cancer vaccines by modulating T cells and the tumour microenvironment","volume":"25","author":"Baharom","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2026.05.005_bib57","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1016\/j.cell.2021.08.020","article-title":"Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors","volume":"184","author":"Burger","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.05.005_bib58","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jid.2025.01.015","article-title":"Multiomic Sequencing of Intermediate- to High-Risk Cutaneous Squamous Cell Carcinoma Identifies Critical Genes and Expression Patterns Associated with Disease and Poor Outcomes","volume":"145","author":"Nassir","year":"2025","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.immuni.2026.05.005_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2026.05.005_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt214","article-title":"The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote","volume":"41","author":"Liao","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.05.005_bib60","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","author":"Li","year":"2013","journal-title":"arXiv"},{"key":"10.1016\/j.immuni.2026.05.005_bib61","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2026.05.005_bib62","series-title":"Genomics in the cloud: using Docker, GATK, and WDL in Terra","author":"Auwera","year":"2020"},{"key":"10.1016\/j.immuni.2026.05.005_bib63","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2026.05.005_bib64","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl Variant Effect Predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2026.05.005_bib65","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.immuni.2026.05.005_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009557","article-title":"Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes","volume":"17","author":"Wang","year":"2021","journal-title":"PLoS Genet."},{"key":"10.1016\/j.immuni.2026.05.005_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.immuni.2026.05.005_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-023-04764-8","article-title":"PUREE: accurate pan-cancer tumor purity estimation from gene expression data","volume":"6","author":"Revkov","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.immuni.2026.05.005_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2024.103143","article-title":"CellViT: Vision Transformers for precise cell segmentation and classification","volume":"94","author":"H\u00f6rst","year":"2024","journal-title":"Med. Image Anal."},{"key":"10.1016\/j.immuni.2026.05.005_bib82","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nbt.3344","article-title":"Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes","volume":"33","author":"Shukla","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2026.05.005_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-0716-0327-7_16","article-title":"Immunedeconv: An R Package for Unified Access to Computational Methods for Estimating Immune Cell Fractions from Bulk RNA-Sequencing Data","volume":"2120","author":"Sturm","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.immuni.2026.05.005_bib71","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-016-0264-5","article-title":"pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens","volume":"8","author":"Hundal","year":"2016","journal-title":"Genome Med."},{"key":"10.1016\/j.immuni.2026.05.005_bib72","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-15-224","article-title":"MAP-RSeq: Mayo Analysis Pipeline for RNA sequencing","volume":"15","author":"Kalari","year":"2014","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.immuni.2026.05.005_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz114","article-title":"The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.05.005_bib75","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gkz836","article-title":"The International Genome Sample Resource (IGSR) collection of open human genomic variation resources","volume":"48","author":"Fairley","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.05.005_bib76","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","article-title":"Strelka: accurate somatic small-variant calling from sequenced tumor\u2013normal sample pairs","volume":"28","author":"Saunders","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2026.05.005_bib77","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/genetics\/140.2.783","article-title":"The hitchhiking effect on the site frequency spectrum of DNA polymorphisms","volume":"140","author":"Braverman","year":"1995","journal-title":"Genetics"},{"key":"10.1016\/j.immuni.2026.05.005_bib78","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/tpbi.1995.1025","article-title":"Statistical properties of segregating sites","volume":"48","author":"Fu","year":"1995","journal-title":"Theor. Popul. Biol."},{"key":"10.1016\/j.immuni.2026.05.005_bib79","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.2041-210X.2011.00179.x","article-title":"abc: an R package for approximate Bayesian computation (ABC)","volume":"3","author":"Csill\u00e9ry","year":"2012","journal-title":"Methods Ecol. Evol."},{"key":"10.1016\/j.immuni.2026.05.005_bib80","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1214\/11-AAP824","article-title":"Population Genetics of Neutral Mutations in Exponentially Growing Cancer Cell Populations","volume":"23","author":"Durrett","year":"2013","journal-title":"Ann. Appl. Probab."},{"key":"10.1016\/j.immuni.2026.05.005_bib81","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-018-2239-6","article-title":"Benchmarking the HLA typing performance of Polysolver and Optitype in 50 Danish parental trios","volume":"19","author":"Matey-Hernandez","year":"2018","journal-title":"BMC Bioinform."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326002165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326002165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:30:25Z","timestamp":1793107825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761326002165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1074761326002165"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2026.05.005","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoediting restricts clonal neoantigens in primary, treatment-naive human tumors","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2026.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}